Sadhana Nitro Chem Ltd
Incorporated in 1973, Sadhana Nitro Chem Ltd manufactures chemical intermediates, heavy organic chemicals performance chemicals, and wireless network equipment and services[1]
- Market Cap ₹ 209 Cr.
- Current Price ₹ 6.35
- High / Low ₹ 74.0 / 6.35
- Stock P/E 27.7
- Book Value ₹ 8.52
- Dividend Yield 2.37 %
- ROCE 5.88 %
- ROE 2.98 %
- Face Value ₹ 1.00
Pros
- Stock is trading at 0.77 times its book value
- Company has been maintaining a healthy dividend payout of 76.6%
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 9.31% over past five years.
- Company has a low return on equity of 2.20% over last 3 years.
- Company might be capitalizing the interest cost
- Promoters have pledged or encumbered 52.7% of their holding.
- Company has high debtors of 270 days.
- Promoter holding has decreased over last 3 years: -9.12%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 9m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
32 | 48 | 36 | 55 | 114 | 267 | 106 | 103 | 132 | 143 | 190 | 166 | |
34 | 52 | 34 | 47 | 79 | 147 | 77 | 80 | 117 | 122 | 149 | 123 | |
Operating Profit | -2 | -4 | 2 | 8 | 35 | 120 | 29 | 23 | 15 | 21 | 41 | 42 |
OPM % | -7% | -8% | 5% | 15% | 31% | 45% | 27% | 23% | 11% | 15% | 22% | 26% |
12 | 14 | 0 | 0 | 0 | 1 | 2 | 5 | 5 | 2 | 4 | 2 | |
Interest | 6 | 5 | 5 | 6 | 5 | 12 | 3 | 3 | 5 | 10 | 17 | 18 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 6 | 6 | 6 | 8 | 15 | 15 |
Profit before tax | 1 | 3 | -5 | 1 | 28 | 107 | 22 | 19 | 9 | 6 | 13 | 12 |
Tax % | 148% | -35% | 0% | 0% | -11% | 29% | 34% | 15% | 30% | 44% | 68% | 34% |
-1 | 4 | -5 | 1 | 31 | 76 | 15 | 16 | 6 | 3 | 4 | 8 | |
EPS in Rs | -0.02 | 0.13 | -0.16 | 0.02 | 0.97 | 2.38 | 0.46 | 0.50 | 0.20 | 0.10 | 0.12 | 0.23 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 47% | 95% | 91% | 44% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 9% |
3 Years: | 8% |
TTM: | -13% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | -12% |
3 Years: | 7% |
TTM: | 85% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | -8% |
3 Years: | -56% |
1 Year: | -89% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 4% |
3 Years: | 2% |
Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 14 | 20 | 20 | 25 | 33 |
Reserves | -11 | -7 | -12 | 1 | 37 | 96 | 107 | 116 | 141 | 206 | 202 | 248 |
41 | 37 | 44 | 36 | 16 | 8 | 46 | 83 | 116 | 139 | 233 | 247 | |
22 | 26 | 27 | 37 | 78 | 64 | 53 | 91 | 110 | 61 | 73 | 109 | |
Total Liabilities | 62 | 66 | 68 | 83 | 139 | 177 | 216 | 304 | 386 | 426 | 532 | 637 |
26 | 31 | 29 | 37 | 50 | 76 | 84 | 78 | 75 | 144 | 156 | 159 | |
CWIP | 9 | 9 | 9 | 9 | 11 | 2 | 15 | 23 | 68 | 28 | 53 | 100 |
Investments | 0 | 0 | 0 | 0 | 0 | 5 | 6 | 6 | 7 | 6 | 6 | 0 |
28 | 26 | 30 | 37 | 78 | 94 | 111 | 197 | 236 | 248 | 317 | 378 | |
Total Assets | 62 | 66 | 68 | 83 | 139 | 177 | 216 | 304 | 386 | 426 | 532 | 637 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
6 | 9 | -1 | 9 | 35 | 53 | -17 | 1 | -5 | -38 | -3 | 48 | |
11 | -0 | -0 | -1 | -6 | -25 | -22 | -23 | -39 | -53 | -65 | -89 | |
-18 | -9 | 2 | -25 | -13 | -23 | 30 | 30 | 46 | 72 | 42 | 25 | |
Net Cash Flow | -1 | 0 | 1 | -16 | 16 | 5 | -9 | 7 | 2 | -19 | -26 | -16 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 68 | 56 | 131 | 68 | 49 | 21 | 100 | 173 | 113 | 167 | 242 | 270 |
Inventory Days | 214 | 102 | 176 | 222 | 184 | 217 | 641 | 600 | 789 | |||
Days Payable | 253 | 226 | 395 | 350 | 195 | 64 | 272 | 234 | 282 | |||
Cash Conversion Cycle | 30 | -68 | -88 | -59 | 37 | 174 | 469 | 539 | 113 | 167 | 242 | 776 |
Working Capital Days | -39 | -7 | 23 | -12 | -81 | 30 | 218 | 291 | 279 | 402 | 365 | 373 |
ROCE % | -13% | 0% | 16% | 62% | 136% | 18% | 12% | 6% | 5% | 7% | 6% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Director
9h - Part A of Schedule III (Listing Regulation) we hereby inform you about the following change in composition of Board, Mr. Uday K Laud (DIN: 10829837), …
- Closure of Trading Window 27 Jun
-
Announcement under Regulation 30 (LODR)-Change in Management
3 Jun - Appointment of Mr. Aditya Suresh Shelke as Senior Management in Secretarial Team from June 2, 2025.
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 19 May
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 16 May
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
SNCL is an ISO 9001:2015 certified and a government-recognized 2-Star Golden Export House. It is in the business of chemical and chemical products, pharma, medicinal chemicals, and intermediates